Interferon alpha for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus. Hepatitis-HIV Spanish Study Group.
about
Fast relapse and high drop out rate of 48 weeks daily interferon monotherapy in HIV-infected patients with chronic hepatitis C.Impact of highly active antiretroviral therapy and immunologic status on hepatitis C virus quasispecies diversity in human immunodeficiency virus/hepatitis C virus-coinfected patients.Hepatitis C Viral Kinetics During Treatment With Peg IFN-alpha-2b in HIV/HCV Coinfected Patients as a Function of Baseline CD4+ T-Cell CountsDiagnosis, management, and treatment of hepatitis C: an updateDiagnosis, management, and treatment of hepatitis CReciprocal interaction of human immunodeficiency virus and hepatitis C virus infectionsCoinfection with HIV and HCV: more questions than answers?Management of chronic viral hepatitis in HIV-infected patients: Spanish Consensus Conference. October 2000.Treatment of hepatitis C and anemia in human immunodeficiency virus-infected patients.Hepatitis C and HIV co-infection: a reviewClinical experiences with interferon as monotherapy or in combination with ribavirin in patients co-infected with HIV and HCV.Hepatitis C and human immunodeficiency virus infection.Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patientsHIV and HCV coinfection in haemophilia.When to treat patients with chronic hepatitis C.Update on Hepatitis C Virus and HIV Coinfection.New hopes for HIV and HCV coinfection in 2004.Treatment of SIV-infected sooty mangabeys with a type-I IFN agonist results in decreased virus replication without inducing hyperimmune activationTherapy of hepatitis C in patients with HIV infection.Treatment of hepatitis C in HIV-coinfected patients.The acceptability and feasibility of peer worker support role in community based HCV treatment for injecting drug users.Liver enzyme alterations in HCV-monoinfected and HCV/HIV-coinfected patientsHepatitis C Virus and HIV Type 1 Co-Infection.Characteristics and prospects for hepatitis C therapy of an HIV-HCV coinfected population followed at a reference HIV center.HIV and hepatitis C co-infection.Characteristics of hepatitis C virus infection in HIV-infected people.Adenovirus vectors block human immunodeficiency virus-1 replication in human alveolar macrophages by inhibition of the long terminal repeat.Review article: interferon and hepatitis C--factors predicting therapeutic outcome.Interferon treatment of two patients with quadruple infection with hepatitis C virus (HCV), human immunodeficiency virus (HIV), hepatitis G virus (HGV), and TT virus (TTV).Reduction in liver-related hospital admissions and deaths in HIV-infected patients since the year 2002.Response rates to pegylated interferon and ribavirin in HCV/HIV coinfection: a research synthesis.Management of Hepatitis C in HIV-infected Patients.British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy.[Alpha-interferon versus peg-interferon associated to ribavirin in the treatment of genotype 1 hepatitis C virus and human immunodeficiency virus coinfected patients].BHIVA guidelines on HIV and chronic hepatitis: coinfection with HIV and hepatitis C virus infection (2005).BHIVA guidelines: coinfection with HIV and chronic hepatitis C virus.Poor response to interferon treatment for chronic hepatitis C in human immunodeficiency virus-infected haemophiliacs.T-lymphocyte populations in hepatitis C and HIV co-infected patients treated with interferon-alfa-2a and ribavirin.KASL clinical practice guidelines: management of hepatitis C.AIDS Clinical Research in Spain-Large HIV Population, Geniality of Doctors, and Missing Opportunities.
P2860
Q24804388-DA8F3E5E-D612-4CF5-A91C-A28E5C3890CCQ27473086-D0C634A1-1C70-44CF-A89D-310FE55303F4Q27490439-D8F5CFA7-0CF4-4B3D-BC2B-CE6246FF4E44Q29619682-50020B6C-0C81-4201-B188-D5C030288275Q29620656-7C4EC6D8-4B78-4514-8751-E22A09AB2625Q33999381-2122E3AC-A38F-4131-B4AA-700A22C5C989Q34113786-3A70F8BB-E51C-4011-B2DC-9D0648985594Q34614976-61224486-6747-411D-9374-474904F6D22DQ34631679-670C6807-529C-40B3-99B7-3B1FF594436FQ34782891-DA974946-CB40-4B92-997F-FA5EFDA8F41EQ34789841-84A3354D-0D7D-4C39-B3C7-396BB8AA4ECCQ34984125-BDF02E1A-EFF7-4144-81BD-F0557F40749FQ35595809-ED04A6E4-6F2B-4045-916A-08EBA1C967EFQ35666754-046474C3-7AB2-43AB-9906-CF598A6E6CBAQ35831941-C27C5E9F-64F1-46FC-9454-6F46428D8C76Q35906047-BF946981-6D59-451F-A7FD-A7B88B4BABD6Q35912407-AA7CD2F5-9A77-4D12-AA4A-8CEA57752C68Q36057594-837CF816-B5C4-4C2A-A908-51388256AAC9Q36162359-4D745B9F-D7D2-4603-8003-1DFA3DE696DFQ36409500-220889D2-FC51-46BB-B6A1-98895E157EC5Q36535234-D297161D-01E5-4E1E-AD90-31C12CE0C424Q37063901-05C46038-EC68-41C9-B411-1138F96CD64AQ37481988-AD48A4B2-7E81-43EC-B415-1E15B0280543Q40353664-FAECA1D2-21E3-4994-9729-3562E6D9394EQ40395267-2E98BBC2-BFB8-4E33-BB0A-F224D85B356CQ40663778-0FF6BB1C-5FB6-4132-8C67-C797B922CED4Q42428565-BA310CB1-6178-46E9-AC76-AE98E22E5F3FQ42989240-037CDB5C-E705-4F64-B1BB-0F472F2A9CA2Q42995643-FEAD44BC-0B7E-400A-98A3-6CCF82F24260Q43033708-0C5EFA86-8AE9-4806-85E8-FCA091B5D0D2Q43036709-38A015A3-6C82-436D-925F-61AB2512D621Q43497594-72D843DC-F09E-4733-B60C-92E549C8CD5AQ43818117-6D5ED6F7-D463-4E94-B31C-B6848B709BD6Q44679671-F64BB1EC-9FF2-4CB4-B442-868F6900EB4AQ45436276-EEADE78B-6643-427A-A18C-1D26D9CEFE22Q45711099-4FB8FA8D-25FB-4CFF-BB77-CF57EB72B7DDQ45739305-BBE98B16-CE0C-454A-BED0-179E4A42E004Q50583247-5DC672D8-31E8-47AB-82A0-A4D23DE2BAFDQ51836024-B33DECC8-B86E-4A64-B04E-40EB0782B621Q55698444-9E5CFAB5-25E2-4A43-8C28-0CCFB97582D1
P2860
Interferon alpha for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus. Hepatitis-HIV Spanish Study Group.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Interferon alpha for the treat ...... titis-HIV Spanish Study Group.
@en
Interferon alpha for the treat ...... titis-HIV Spanish Study Group.
@nl
type
label
Interferon alpha for the treat ...... titis-HIV Spanish Study Group.
@en
Interferon alpha for the treat ...... titis-HIV Spanish Study Group.
@nl
prefLabel
Interferon alpha for the treat ...... titis-HIV Spanish Study Group.
@en
Interferon alpha for the treat ...... titis-HIV Spanish Study Group.
@nl
P2093
P356
P1476
Interferon alpha for the treat ...... titis-HIV Spanish Study Group.
@en
P2093
Carballo E
Castilla J
Colmenero M
García-Samaniego J
González J
González-Lahoz J
Martínez-Odriozola P
P304
P356
10.1093/CLINIDS/23.3.585
P407
P577
1996-09-01T00:00:00Z